Telomerase activation occurs in 85–90% of all human cancers (Kim et al., 1994; Shay and Bacchetti, 1997) while 10–15% of cancers maintain their telomeres through a DNA recombination pathway (named ALT for alternative lengthening of telomeres) (Bryan et al., 1997). This evidence concerns the gene GPT and cancer.